These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 4140818)

  • 1. [Mechanism of rabbit platelet aggregation inhibition induced by cobalt(II)-ions].
    Krantz S; Bartolomäus A; Lober M
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1974; 101(5):785-91. PubMed ID: 4140818
    [No Abstract]   [Full Text] [Related]  

  • 2. Thrombin interaction with human platelets. Potentiation of thrombin-induced aggregation and release by inactivated thrombin.
    Phillips DR
    Thromb Diath Haemorrh; 1974 Sep; 32(1):207-15. PubMed ID: 4454040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of phospholipase inhibitor mepacrine on platelet aggregation, the platelet release reaction and fibrinogen binding to the platelet surface.
    Winocour PD; Kinlough-Rathbone RL; Mustard JF
    Thromb Haemost; 1981 Jun; 45(3):257-62. PubMed ID: 7281105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of amino sugars on platelet aggregation and on fibrinogen binding.
    Kinlough-Rathbone RL; Packham MA; Mustard JF
    Thromb Haemost; 1984 Aug; 52(1):75-80. PubMed ID: 6495268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitory effect of zinc ions on platelet aggregation and serotonin release reaction.
    Chvapil M; Weldy PL; Stankova L; Clark DS; Zukoski CF
    Life Sci; 1975 Feb; 16(4):561-71. PubMed ID: 1123959
    [No Abstract]   [Full Text] [Related]  

  • 6. Proceedings: Refractoriness in blood platelets: effect of prior exposure to aggregating agents on subsequent aggregation responses.
    Evans RJ; Gordon JL
    Br J Pharmacol; 1974 May; 51(1):123P. PubMed ID: 4441772
    [No Abstract]   [Full Text] [Related]  

  • 7. Inhibition and reversal of ristocetin - induced platelet aggregation.
    Howard MA
    Thromb Res; 1975 Jun; 6(6):489-99. PubMed ID: 239463
    [No Abstract]   [Full Text] [Related]  

  • 8. The fibrinogen gamma chain dodecapeptide inhibits agonist-induced aggregation of rabbit platelets and fibrinogen binding to rabbit glycoprotein IIb-IIIa.
    Rand ML; Packham MA; Taylor DM; Yeo EL; Gemmell CH; Patil S; Lam SC
    Thromb Haemost; 1999 Dec; 82(6):1680-6. PubMed ID: 10613655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concentration effects of platelets, fibrinogen and thrombin on platelet aggregation and fibrin clotting.
    Chao FC; Tullis JL; Kenney DM; Conneely GS; Doyle JR
    Thromb Diath Haemorrh; 1974 Sep; 32(1):216-31. PubMed ID: 4454041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The influence of prostaglandins E1 and E2 on platelet aggregation in mammals.
    Sinakos Z; Zamboulis C; Kartalis G; Koratzis J; Valtis D
    Haematologica; 1974 Jun; 59(2):173-80. PubMed ID: 4216529
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of cyclonamine on blood platelets. II. Changes in the surface charge and inhibition of the release reaction.
    Sack ES; Cerutti N
    Medicina (B Aires); 1973; 3(6):685-94. PubMed ID: 4805048
    [No Abstract]   [Full Text] [Related]  

  • 12. Anti-platelet effects of isocarbacyclin methyl ester on human and rabbit platelets in vitro.
    Inoue K; Aoki Y; Kitahara S; Kiyoki M; Araki H
    Arzneimittelforschung; 1995 Sep; 45(9):975-9. PubMed ID: 7488316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Use of a thromboxane synthetase inhibitor for the protection of platelet number and function during extracorporeal circulation. Experimental study].
    Massonnet Castel S; Pelissier E; Fabiani JN; Terrier E
    Agressologie; 1983 Dec; 24(12):605-8. PubMed ID: 6686919
    [No Abstract]   [Full Text] [Related]  

  • 14. Prevention of platelet contact activation by prostaglandin E1 released from polyurethane surfaces.
    Lin JY; Okano T; Dost L; Feijen J; Kim SW
    Trans Am Soc Artif Intern Organs; 1985; 31():468-73. PubMed ID: 3837491
    [No Abstract]   [Full Text] [Related]  

  • 15. [Platelet aggregation from interaction between washed platelets and purified thrombin, plasmin or trypsin (author's transl)].
    Matsuoka M; Watanabe T; Koike K; Sakuragawa N
    Rinsho Ketsueki; 1974 May; 15(5):519-23. PubMed ID: 4277899
    [No Abstract]   [Full Text] [Related]  

  • 16. Platelet interaction with polymerizing fibrin.
    Niewiarowski S; Regoeczi E; Stewart GJ; Senyl AF; Mustard JF
    J Clin Invest; 1972 Mar; 51(3):685-99. PubMed ID: 4622107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Changes in thrombocyte aggregation caused by administration of metal salts to rabbits].
    Fiedler H; Herrmann I
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1971; 96(2):224-30. PubMed ID: 4111656
    [No Abstract]   [Full Text] [Related]  

  • 18. [Inhibition of platelet function (mode of action of platelet inhibitors) (author's transl)].
    Baumgartner HR
    Ther Umsch; 1977 May; 34(5):341-6. PubMed ID: 867315
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of a potent thrombin inhibitor, No. 407, on platelet function in vitro and in vivo.
    Hara H; Tamao Y; Kikumoto R; Funahara Y; Hijikata A; Okamoto S
    Kobe J Med Sci; 1980 Mar; 26(1):47-60. PubMed ID: 7392549
    [No Abstract]   [Full Text] [Related]  

  • 20. Studies on pig blood platelet responses to peroxynitrite action.
    Nowak P; Wachowicz B
    Platelets; 2001 Sep; 12(6):376-81. PubMed ID: 11672476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.